A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

NCT07692165 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: INT-210 Capsule
DRUG: INT-210 Capsule

Sponsor

Innatus Therapeutics (Shanghai) Co., Ltd.